Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 413 | -717 | -51 | 247 | -554 |
| Depreciation Amortization | 12 | 6 | 10 | 17 | 28 |
| Accounts receivable | -774 | -16 | N/A | 542 | 133 |
| Accounts payable and accrued liabilities | -113 | 191 | -22 | 83 | 251 |
| Other Working Capital | -30 | -212 | -715 | 558 | 252 |
| Other Operating Activity | 914 | -169 | 15 | -610 | -368 |
| Operating Cash Flow | $423 | $-917 | $-764 | $836 | $-257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | -8 | -6 | -1 | -13 |
| Other Investing Activity | 0 | 0 | 2 | 1 | -3 |
| Investing Cash Flow | $-65 | $-8 | $-4 | $0 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 450 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 10 | 1 | N/A | N/A | N/A |
| Financing Cash Flow | $460 | $1 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,039 | 1,964 | 2,732 | 1,895 | 2,168 |
| End Cash Position | 1,858 | 1,039 | 1,964 | 2,732 | 1,895 |
| Net Cash Flow | $819 | $-925 | $-768 | $836 | $-273 |
| Free Cash Flow | |||||
| Operating Cash Flow | 423 | -917 | -764 | 836 | -257 |
| Capital Expenditure | -65 | -8 | -6 | -1 | -13 |
| Free Cash Flow | 359 | -926 | -769 | 835 | -270 |